IUPAC Wire

Germany, 21-24 October 2018. A contribution to travel expenses will be provided.

The prize is to be awarded to an internationally recog- nized scientist, whose activities or published accounts have made an outstanding contribution in the field of flow chemistry, microfluidics, micro fabrication, and micro systems engineering in academia or industry. of what the individual considers to be his/her activities, The Prize, of USD 7 500, has been established by accomplishments and/or publications that have had the a generous gift from the Hungarian Technology com- most significant impact upon the field of Flow Chem- pany ThalesNano Inc. to acknowledge the key role istry. The material will be forwarded confidentially to that flow chemistry plays towards the improvement of an independent selection committee appointed by the chemical processes. IUPAC Committee on Chemistry and Industry. Applications should be received by nomination only, Nomination materials should be submitted by 31 with just one person acting as the nominator, with a to- January 2018 to the chair of the IUPAC Committee tal of five (5) individuals as referees overall. The pack- on Chemistry and Industry, Dr. Carolyn Ribes, by email age must be submitted electronically and should con- at: [email protected] tain a complete resume, a professional autobiography of not more than two pages, and a one-page summary https://iupac.org/what-we-do/awards/

See also www.iupac.org/ Stamps International publications/ci/indexes/stamps.html Holý Chemistry active until his retirement in 2011. The prevention and treatment of vi- An indefatigable researcher and prolif- ral infectious diseases, including the com- ic writer, Holý was the author or co-author mon cold, influenza, hepatitis, yellow fever, of some 600 publications and 60 patents, and Acquired Immunodeficiency Syndrome many of them achieved together with his (AIDS), continues to challenge public health longtime collaborator Erik De Clercq, a re- systems throughout the world. A huge nowned immunologist and microbiologist at amount of resources is dedicated to under- the Rega Institute for Medical Research at standing the molecular basis of these afflic- the Catholic University in , Belgium. tions and devising the means to prevent, Their concerted work led to the discovery of treat, or cure them. Chemistry, biology, med- important drugs, such as tenofovir disoprox- icine, and related fields play an important il, which was approved by the U.S. Food and role in basic and applied research aimed at accomplish- Drug Administration in 2001 to prevent and treat HIV, ing these goals. often in combination with other antiretroviral agents, The stamp illustrated in this note honors Antonín and in 2008 for the treatment of chronic hepatitis B. Holý (1936-2012), a Czech chemist best known for his Sold under the trade name Viread, pioneering contributions to the development of antiret- is a nucleotide reverse transcriptase inhibitor that works roviral drugs used in the fight against HIV (Human Im- by decreasing the ability of the viruses to replicate. Sig- munodeficiency Virus) and hepatitis B infections. Holý nificantly, it is included in the World Health Organiza- studied organic chemistry from 1954 to 1959 in the Fac- tion’s List of Essential Medicines, a compilation of the ulty of Science at Charles University in . In 1960, most important drugs needed in a health system. he joined the Institute of Organic Chemistry and Bio- For a personal account on the development of anti- chemistry (IOCB) of the Czechoslovak Academy of Sci- viral drugs during the past 50 years, see: De Clercq, E. ences, where he became lead scientist in 1967 and chief Acta Pharm Sin. B. 2015, 5:520-543. of the Department of Nucleic Acid Chemistry in 1987. He was head of the IOCB from 1994 to 2002 and remained Written by Daniel Rabinovich

26 Chemistry International January-March 2018